We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on COVID-19

16 Apr 2020 14:00

RNS Number : 9171J
Evraz Plc
16 April 2020
 

Update on COVID-19

 

16 April 2020 - EVRAZ plc ("EVRAZ or the "Group") today announces an update on the impact of COVID-19 on its business.

Group focus and priorities

The Group is closely monitoring the development of the COVID-19 pandemic and its impact on our employees, our operations and the broader stakeholder base. EVRAZ's immediate focus is on doing everything in its power to protect the lives and health of our employees and minimise the negative impact on our facilities and the communities in which we operate.

During and since March 2020, in response to the coronavirus pandemic the Group has introduced additional safety measures to protect its people and ensure continued operations.

These include:

· Significant reduction of domestic and cancellation of overseas business travel;

· Two-week isolation, with full salary, for all employees returning from trips abroad, either personal or work-related;

· Enabling remote working, provision of additional personal protection equipment for employees who must come to work, including eye protectors, respirators and gloves;

· Installation of thermal imaging devices and pyrometers at the entrances to our facilities to monitor people's temperatures;

· Elimination to the extent possible of large gatherings (with social distancing when they must take place), and cancellation of all major corporate, sporting and entertainment events;

· Increase of supplies of antiseptic and disinfectant products in communal areas, regular sanitation of facilities and transport;

· Campaigns to raise awareness among employees and contractors on behavioural features, social distancing and personal protection.

The Group is monitoring the spread of coronavirus and working with healthcare facilities and insurance organisations to take proactive decisions aimed at safeguarding its employees and their families. Currently there are no confirmed COVID-19 cases in EVRAZ.

Update on our operations and outlook 

The Group remains closely focused on its operations, including logistics, supply and technological processes. At present, EVRAZ is facing no significant issues with the production or supply of raw materials and other goods. Shipments continue, and raw material deliveries to enterprises are stable.

However, in the near term, we expect domestic steel demand to fall due to the significant economic down-turn that the restrictions imposed due to COVID-2019 are causing worldwide, including in Russia. This will, no doubt, affect firstly our construction products sales and then our railway products sales, to a slightly lesser extent.

We expect the impact on exports to be less significant. This is due to the recent rouble devaluation and EVRAZ's ability to redirect steel from domestic sales to export markets.

While the impact on the Group has been limited so far, we are likely to experience challenges in the near term. While our enterprises have been operating at full capacity, the situation is likely to be more complex in May and June. In the light of this, EVRAZ is working on a comprehensive package of optimisation measures that we expect to partially mitigate these negative effects.

Our financial position

The Group remains well capitalised with a strong liquidity cushion.

As at 31 December 2019, our net debt amounted to US$3,445 million. This reflected cash of US$1,423 million. Short-term loans and the current portion of long-term loans stood at US$140 million. Total scheduled debt maturities during 2020 will amount to no more thanUS$52 million.

In March 2020, EVRAZ paid interim dividends to its shareholders amounting to US$580.8 million, US$0.40 per share.

In addition, also in March 2020, EVRAZ signed a US$750 million 5-year committed syndicated unsecured credit facility. This facility was arranged and fully underwritten by a group of 10 international banks and is available for drawing until 18 March 2021. The proceeds of the facility will be used for general corporate purposes, including refinancing of the public debt maturities upcoming in Q1 2021.  

In March and April, the Group also added RUB20 billion to its cash cushion by utilisation of its committed and uncommitted credit lines in Russia, due 2023.

The first sizeable maturities are due in Q1 2021 which should be comfortably covered by our existing cash balances and committed credit facilities.

Despite Covid-19 related challenges and market downturns, EVRAZ remains committed to its long-term strategic goals, sustainability principles and high standards of corporate governance and control.

 

For more information, please contact:

 

Investor Relations

Tel: +7 495 232 1370

Email: ir@evraz.com

 

Media Relations

Tel: +7 495 937 6871

Email: media@evraz.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUAGCUPUGPQ
Date   Source Headline
28th Feb 20237:00 amEQSDISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
27th Feb 20237:00 amEQSCLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022
28th Dec 20228:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
28th Dec 20227:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
23rd Dec 20228:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
23rd Dec 20227:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
19th Dec 202212:00 pmEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
19th Dec 202211:00 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
8th Dec 20229:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20229:15 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
8th Dec 20228:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20228:16 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
9th Nov 20221:45 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
9th Nov 202212:46 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
2nd Nov 20222:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
2nd Nov 20221:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
4th Aug 20227:39 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
4th Aug 20227:37 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
28th Jul 20222:33 pmEQSEVRAZ plc: Important notice to noteholders
28th Jul 20222:32 pmEQSEVRAZ plc: Important notice to noteholders
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
18th Jul 20228:39 amEQSEVRAZ plc: Termination of the registry and associated services
18th Jul 20228:38 amEQSEVRAZ plc: Termination of the registry and associated services
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.